- Home
- TPH vs MLTX Comparison
TPH vs MLTX Comparison
Compare TPH & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- MLTX
- Stock Information
- Founded
- TPH 2009
- MLTX 2021
- Country
- TPH United States
- MLTX Switzerland
- Employees
- TPH N/A
- MLTX N/A
- Industry
- TPH Homebuilding
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- MLTX Health Care
- Exchange
- TPH Nasdaq
- MLTX Nasdaq
- Market Cap
- TPH 2.8B
- MLTX 2.8B
- IPO Year
- TPH N/A
- MLTX N/A
- Fundamental
- Price
- TPH $37.16
- MLTX $59.44
- Analyst Decision
- TPH Buy
- MLTX Strong Buy
- Analyst Count
- TPH 6
- MLTX 7
- Target Price
- TPH $42.00
- MLTX $74.83
- AVG Volume (30 Days)
- TPH 921.2K
- MLTX 446.5K
- Earning Date
- TPH 10-23-2025
- MLTX 08-05-2025
- Dividend Yield
- TPH N/A
- MLTX N/A
- EPS Growth
- TPH N/A
- MLTX N/A
- EPS
- TPH 3.96
- MLTX N/A
- Revenue
- TPH $4,041,885,000.00
- MLTX N/A
- Revenue This Year
- TPH N/A
- MLTX N/A
- Revenue Next Year
- TPH $1.33
- MLTX N/A
- P/E Ratio
- TPH $9.38
- MLTX N/A
- Revenue Growth
- TPH N/A
- MLTX N/A
- 52 Week Low
- TPH $27.90
- MLTX $31.42
- 52 Week High
- TPH $46.91
- MLTX $61.87
- Technical
- Relative Strength Index (RSI)
- TPH 67.11
- MLTX 68.36
- Support Level
- TPH $34.67
- MLTX $56.81
- Resistance Level
- TPH $35.55
- MLTX $61.87
- Average True Range (ATR)
- TPH 0.82
- MLTX 2.46
- MACD
- TPH 0.10
- MLTX 0.41
- Stochastic Oscillator
- TPH 90.77
- MLTX 75.33
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company is engaged in the design, construction, and sale of single-family attached and detached homes in different states across the United States. Its operations are organized into two principal businesses: homebuilding. which generates key revenue, and financial services. The homebuilding business has three reportable operating segments, based on the geographical layout of the markets, and includes West region, Central region, and East region. The company's financial services operation is comprised of its Tri Pointe Connect mortgage financing operations, Tri Pointe Assurance title and escrow services operations, and Tri Pointe Advantage property and casualty insurance agency operations.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.